FLGT Q3 2019 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q3 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$10M+83.9% YoY

Gross Profit

$6M62.5% margin

Operating Income

$2M14.6% margin

Net Income

$1M14.1% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+22.8%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$4M

Stock-Based Comp.

$951,000

Balance Sheet

Total Assets

$61M

Total Liabilities

$7M

Stockholders' Equity

$55M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$6M	+83.9%
Gross Profit	$6M	$3M	+114.5%
Operating Income	$2M	-$846,000	+278.4%
Net Income	$1M	-$595,000	+345.7%

Geographic Segments

UNITED STATES

$8M82%

Other Countries

$1M13%

CANADA

$548,0005%